Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel, MBRS Special Emphasis Panel.
Date: July 30, 2002.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, NIGMS, Office of Scientific Review, Natcher Building, Room 1AS-13, Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Helen R Sunshine, PhD, Chief, Office of Scientific Review, NIGMS, Natcher Building, Room 1AS-13, Bethesda, MD 20892. (301) 594-2881.Start Signature
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
Dated: July 22, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-18936 Filed 7-25-02; 8:45 am]
BILLING CODE 4140-01-M